Epidemiology of the insulin-like growth factor system in three ethnic groups.

The insulin-like growth factor (IGF) system, comprising insulin-like growth factor I (IGF-I), insulin-like growth factor II (IGF-II), and their binding proteins (IGFBPs), is linked to cell growth, the development of cardiovascular disease, and several cancers. Little is known about its epidemiology. The authors studied relations of the IGF system to anthropometric and metabolic variables in three population-based ethnic groups in Manchester, England, in 1994-1998 with differing disease risks: African Caribbean (n = 193), Pakistani (n = 130), and local Europeans(n = 142). Standardized anthropometry, glucose tolerance tests, and serum assays were performed. Body mass indices (BMIs) were high in all groups. IGF-I levels were highest in normoglycemic African Caribbeans and declined with age (r = -0.28). IGF-II levels were greatest in Europeans. IGFBP-1 concentrations increased with age in Pakistanis (r = 0.20) and Europeans (r = 0.29), but not in African Caribbeans (r = 0.06), and were inversely related to BMI (r = -0.37). Age- and sex-adjusted IGFBP-1 was inversely related to fasting insulin and proinsulin in all groups; participants with newly detected diabetes were relatively insulinopenic but had higher IGFBP-1 concentrations. Nonesterified (free) fatty acid (NEFA) concentrations increased with declining glucose tolerance. In multiple regression analysis, IGFBP-1 was independently and negatively related to fasting insulin, BMI, and African-Caribbean compared with European ethnicity but positively related to age, fasting glucose, and NEFA. IGF-I was inversely related only to age, NEFA, and Pakistani ethnicity. IGF-II showed a strong ethnic difference but was unrelated to other variables. These data indicate considerable potential for exploring disease-IGF system relations in population samples.

[1]  L. Riste,et al.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations , 2001, Diabetologia.

[2]  B. Balkau,et al.  Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. , 2001, International journal of epidemiology.

[3]  S. Anderson,et al.  Hypertension in four African-origin populations: current ‘Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease , 2001, Journal of hypertension.

[4]  A. Casellas,et al.  Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes , 2000 .

[5]  A. Casellas,et al.  Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. , 2000, The Journal of clinical investigation.

[6]  D. Barker,et al.  Motheres, babies and health in later life , 1999 .

[7]  W. Wong,et al.  Serum concentrations of insulin, insulin-like growth factor-I and insulin-like growth factor binding proteins are different between white and African American girls. , 1999, The Journal of pediatrics.

[8]  R. Bhopal,et al.  Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study , 1999, BMJ.

[9]  S. Grottoli,et al.  Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients , 1999, International Journal of Obesity.

[10]  B. Balkau,et al.  Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. , 1999, Diabetes care.

[11]  N. Day,et al.  Fasting proinsulin concentrations predict the development of type 2 diabetes. , 1999, Diabetes care.

[12]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[13]  D. Grobbee,et al.  Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Meir J. Stampfer,et al.  Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .

[15]  P. Bennett,et al.  Intact Proinsulin, des 31,32 Proinsulin, and Specific Insulin Concentrations Among Nondiabetic and Diabetic Subjects in Populations at Varying Risk of Type 2 Diabetes , 1998, Diabetes Care.

[16]  L. Giudice,et al.  Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  D. Cook,et al.  Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London , 1997, Heart.

[18]  Q. Li,et al.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.

[19]  H. Orskov,et al.  The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. , 1997, The Journal of clinical endocrinology and metabolism.

[20]  J. McGarry,et al.  The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. , 1997, The Journal of clinical investigation.

[21]  L. Murphy,et al.  Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. , 1997, The Journal of clinical endocrinology and metabolism.

[22]  J. Yudkin,et al.  The Relationship of Concentrations of Insulin and Proinsulin-Like Molecules With Coronary Heart Disease Prevalence and Incidence: A study of two ethnic groups , 1997, Diabetes Care.

[23]  S. Srinivasan,et al.  Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents: the Bogalusa Heart Study. , 1997, American journal of hypertension.

[24]  E. Barrett-Connor,et al.  Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. , 1997, American journal of epidemiology.

[25]  G. Addison,et al.  Urinary IGF and IGF binding protein‐3 in children with disordered growth , 1997, Clinical endocrinology.

[26]  P. McKeigue,et al.  Cross sectional analysis of mortality by country of birth in england and wales, 1970-92 , 1997, BMJ.

[27]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[28]  M. Alderman,et al.  The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. , 1996, The New England journal of medicine.

[29]  K. D. Hopkins,et al.  Ethnicity affects IGFBP‐3 and IGF‐II in normal healthy young adult subjects , 1996, Clinical endocrinology.

[30]  L. Murphy,et al.  Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice. , 1996, The American journal of physiology.

[31]  N. Chaturvedi,et al.  Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? , 1996, Journal of epidemiology and community health.

[32]  S. Jain,et al.  Hyperinsulinemia in Nondiabetic Asian Subjects Using Specific Assays for Insulin, Intact Proinsulin, and Des-31, 32-Proinsulin , 1996, Diabetes Care.

[33]  P. Delafontaine.  Insulin-like growth factor I and its binding proteins in the cardiovascular system. , 1995, Cardiovascular research.

[34]  K. Brismar,et al.  Effects on glucose tolerance, insulin secretion, insulin‐like growth factor 1 and its binding protein, IGFBP‐1, in a randomized controlled diet and exercise study in healthy, middle‐aged men , 1995, Journal of internal medicine.

[35]  J. Ross,et al.  Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. , 1995, The Journal of clinical investigation.

[36]  R. Balarajan.  Ethnicity and variations in the nation's health. , 1995, Health trends.

[37]  R. Young,et al.  The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[38]  N. Chaturvedi,et al.  Methods for epidemiological surveys of ethnic minority groups. , 1994, Journal of epidemiology and community health.

[39]  U. Stenman,et al.  Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. , 1993, The Journal of clinical endocrinology and metabolism.

[40]  J. Cruickshank,et al.  Clinical features, risk factors, and referral delay in British patients of Indian and European origin with angina matched for age and extent of coronary atheroma. , 1993, BMJ.

[41]  P. Delafontaine,et al.  Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. , 1993, Circulation research.

[42]  R. Young,et al.  Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay. , 1993, The Journal of endocrinology.

[43]  R. Alexander,et al.  Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. , 1993, Circulation research.

[44]  W. Haskell,et al.  Saturated Fat Intake and Insulin Resistance in Men With Coronary Artery Disease , 1991, Circulation.

[45]  J. Cruickshank,et al.  Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure , 1991, The Lancet.

[46]  M. Marmot,et al.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians , 1991, The Lancet.

[47]  P. Björntorp,et al.  Reduced hepatic insulin clearance in rats with dietary-induced obesity. , 1986, Metabolism: clinical and experimental.

[48]  A. Adelstein,et al.  LESSONS FROM THE STUDY OF IMMIGRANT MORTALITY , 1984, The Lancet.

[49]  S. Bentley.  Heat attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites. , 1980, British medical journal.

[50]  D. Beevers,et al.  Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. , 1980, British medical journal.